| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Mar―30 |
Pandemic of the century: COVID-19 in inflammatory rheumatic diseases of a national cohort with 3,532 patients |
Fatma Yurdakul, Hatice Bodur, Ahmet Kıvanç Cengiz, Yunus Durmaz, Mehmet Tuncay Duruöz, Taciser Kaya, et al. (+14) Sertaç Ketenci, Nihan Cüzdan, Tuba Güler, Zafer Günendi, Selda Sarıkaya, Erhan Çapkın, Mustafa Erkut Önder, Meltem Alkan Melikoğlu, Rengin Güzel, Nesrin Şen, Ata Bora Ayna, Özgür Akgül, Erhan Eser, Şebnem Ataman |
| 2 |
[GO] |
2024―Mar―30 |
COVID-19 vaccination rates and factors affecting vaccination in children with rheumatic disease |
Tuncay Aydın, Gülcan Özomay Baykal, Cüneyt Karagöl, Fatih Haşlak, Ebru Oğultekin Vazgeçer, Rüya Torun, et al. (+8) Zehra Kızıldağ, Elif Kılıç Könte, Esma Aslan, Vildan Güngörer, Banu Çelikel Acar, Betül Sözeri, Özgür Kasapçopur, Balahan Makay |
| 3 |
[GO] |
2024―Mar―30 |
Atypical antinuclear matrix protein 2-positive dermatomyositis presenting with anasarca and bulbar weakness after coronavirus disease 2019 infection requiring mechanical ventilation |
Brona Dinneen, John Stack |
| 4 |
[GO] |
2024―Feb―06 |
The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis |
Amra Adrovic, Mehmet Yıldız, Fatih Haşlak, Sezgin Şahin, Oya Köker, Aybüke Günalp, et al. (+2) Kenan Barut, Özgür Kasapçopur |
| 5 |
[GO] |
2024―Feb―06 |
COVID-19-induced digital ischemia in antiphospholipid syndrome |
Sadettin Uslu |
| 6 |
[GO] |
2023―Dec―05 |
Impact of the COVID-19 pandemic on the routine of an infusion center of immunobiologicals from a Brazilian University Hospital |
Thelma Skare, Maria Dorl, Mylene Cordeiro, Barbara Kahlow, Renato Nisihara |
| 7 |
[GO] |
2023―Mar―16 |
Clinical course and prognostic factors of COVID-19 infection in patients with chronic inflammatory-rheumatic disease: A retrospective, case-control study |
Kemal Nas, Ertuğrul Güçlü, Yaşar Keskin, Gamze Dilek, Mehtap Kalçık Unan, Nurselin Can, et al. (+2) İbrahim Tekeoğlu, Ayhan Kamanlı |
| 8 |
[GO] |
2023―Mar―16 |
How do COVID-19 vaccines affect rheumatic diseases? |
Lale Altan, Salim Mısırcı, İlker Yağcı, Meltem Karacaatlı, Feyza Ünlü Özkan, Altuğ Güner, İlknur Aktaş |
| 9 |
[GO] |
2023―Feb―17 |
Efficacy of coronavirus disease 2019 vaccines in patients with rheumatic diseases |
Fatih Taştekin, Meltem Taşbakan, Candan Çiçek, Mehmet Soylu, Figen Yargucu Zihni |
| 10 |
[GO] |
2023―Feb―16 |
Academic publication activities and perspectives of rheumatology practitioners in the COVID-19 pandemic |
Abdulvahap Kahveci, Alper Gümüştepe, Nurhan Güven, İsmihan Sunar, Şebnem Ataman |
| 11 |
[GO] |
2022―Mar―05 |
Impact of vitamin D level and supplementation on systemic lupus erythematosus patients during COVID-19 pandemic |
Yasmin Adel, Mohamed Elgamal, Sherehan Adel Abdelsalam |
| 12 |
[GO] |
2021―Dec―27 |
Is COVID-19 multisystem inflammatory syndrome a new variant of Kawasaki Disease? |
Khawla Abu Hammour, Rana Abu Farha, Qusai Manaseer, Tasnim Dawoud, Walid Abu Hammour |
| 13 |
[GO] |
2021―Aug―06 |
Attitudes of patients with spondylarthritis or rheumatoid arthritis regarding biological treatment during COVID-19 pandemic: A multi-center, phone-based, cross-sectional study |
Coskun Zateri, Murat Birtane, İlknur Aktaş, Selda Sarıkaya, Aylin Rezvani, Lale Altan, et al. (+6) Nigar Dursun, Erbil Dursun, Nurettin Taştekin, Reyhan Çeliker, Şenay Özdolap, Kenan Akgün |
| 14 |
[GO] |
2021―May―31 |
SARS-CoV-2 infection in children with rheumatic disease: Experience of a tertiary referral center |
Betül Sözeri, Ferhat Demir, Sevinç Kalın, Canan Hasbal Akkuş, Enes Salı, Deniz Çakır |
| 15 |
[GO] |
2020―Jul―09 |
Anti-Tumor Necrosis Factor Treatment in Ankylosing Spondylitis may not Relate to Poor Prognosis in COVID-19 |
Nesrin ŞEN, Mehmet Engin TEZCAN |
|
